All market news

Morning movers: Doximity jumps 76.6% while Trade Desk drops 28.1%

Doximity jumped 76.57% before the bell after a revenue beat and modest guide increase, while Atlassian gained 29.74% on stronger cloud growth. The Trade Desk fell 28.13% after revenue growth slowed to 3% and its Q3 guide missed the cited consensus by a wide margin.

YieldCove Desk

3 min read

Share on X
DOCSTEAMTTDFIGSAAOI
A physician conducts a remote consultation beside medical imaging and video-conferencing equipment
Photo: Intel Free Press — Wikimedia Commons (CC BY-SA 2.0; cropped)

Today's Morning Read covers futures, rates and the U.S. jobs calendar. This stock-only brief uses delayed Nasdaq pre-market quotes at 05:40 ET on 7 August 2026, independently checked against TradingView near the same quote cut.

Delayed pre-market snapshot

At the quote cut, DOCS was +76.57% at $36.48, TEAM was +29.74% at $142.94, and TTD was -28.13% at $12.70. Pre-market precedes the 09:30 ET opening auction and is thinner. Consensus means the average analyst estimate; implied volatility (IV) estimates movement, not direction.

TickerPre-market moveDelayed priceConfirmed catalyst
DOCS+76.57%$36.48Revenue beat and a modest full-year revenue-guide increase
TEAM+29.74%$142.9428% revenue growth, 31% cloud growth and an above-consensus Q1 guide
TTD-28.13%$12.703% revenue growth, a revenue miss and a weak Q3 guide
Featured movers — Nasdaq delayed quotes at 05:40 ET on 7 August 2026

DOCS: +76.57% as low expectations meet a revenue beat

Doximity reported fiscal Q1 revenue of $156.6 million, up 7%. StockStory put it 3.5% above consensus and said the full-year revenue midpoint rose to $676 million from $670 million. Official ranges are $170-$171 million for fiscal Q2 and $671-$681 million for the year.

Delayed pre-market

$36.48

+76.57%

Fiscal Q1 revenue

$156.6 million

+7% Y/Y

Fiscal Q1 adjusted EBITDA

$74.8 million

47.7% margin

DOCS: a huge gap can outrun the quarter

Adjusted EBITDA fell to $74.8 million from $79.8 million, and free cash flow fell 34% year over year even as revenue beat expectations. Cboe’s delayed file listed 324 option series and 55,802 contracts of open interest, but options do not trade pre-market. After a 76% stock gap, yesterday’s strikes and IV are not executable opening quotes.

  • Objective levels: the $34.00-$36.96 delayed pre-market range and the $20.66 prior close.
  • Why it matters: the gap reprices low expectations after the beat and guide increase, not a sudden 76% business change.
  • Main risk: slower cash conversion and lower margins can return to focus after the opening.

TEAM: +29.74% after cloud growth reaccelerates

Atlassian reported fiscal Q4 revenue of $1.766 billion, up 28%, including $1.213 billion of cloud revenue, up 31%. Subscription annual recurring revenue reached $6.606 billion, up 23%, while remaining performance obligations rose 44% to $4.817 billion. Benzinga cited a $1.660 billion revenue consensus.

Delayed pre-market

$142.94

+29.74%

Fiscal Q4 revenue

$1.766 billion

+28% Y/Y

Cloud revenue

$1.213 billion

+31% Y/Y

TEAM: strong guide, but the mix still matters

Atlassian guided fiscal Q1 2027 revenue to $1.705-$1.715 billion; Benzinga cited a $1.665 billion consensus. Cboe’s delayed file listed 1,384 option series and 157,325 contracts of open interest. Earnings have passed, so IV can compress even if the stock holds its gap; live spreads and open interest need to be rebuilt after 09:30 ET.

  • Objective levels: the $141.75-$144.99 delayed pre-market range and the $110.17 prior close.
  • Why it matters: faster cloud growth and an above-consensus guide challenge recent AI-disruption fears.
  • Main risk: full-year fiscal 2027 revenue growth is still guided to about 13%, well below the quarter’s 28% pace.

TTD: -28.13% after growth slows to 3%

The Trade Desk reported Q2 revenue of about $715 million, up 3%. Benzinga cited $715.06 million against a $751.39 million consensus and non-GAAP EPS of $0.34 against $0.40. The Q3 revenue floor is $650 million, below Benzinga’s $805.09 million consensus.

Delayed pre-market

$12.70

-28.13%

Q2 revenue

$715 million

+3% Y/Y

Adjusted EBITDA

$241 million

vs $271 million

TTD: execution risk comes before premium

Adjusted EBITDA fell to $241 million from $271 million, and margin narrowed to 34% from 39%. Cboe’s delayed file listed 914 option series, 939,518 contracts of open interest and 175,566 contracts of prior-session volume. That depth does not make a 28% earnings gap routine: opening spreads, IV and assignment risk can all reset together.

  • Objective levels: the $12.66-$13.60 delayed pre-market range and the $17.67 prior close.
  • Why it matters: the miss and guide point to slower ad-platform spending or execution, not just margins.
  • Main risk to the first reaction: retention remained above 95%, so any evidence that the slowdown is temporary could produce a sharp counter-move.

Also on the radar

  • FIGS +26.78% at $14.25 near 05:40 ET: Q2 revenue rose 28.8% to $196.6 million; the company raised its 2026 outlook and increased its repurchase authorization by $100 million. The $13.90-$14.53 pre-market range is the first objective reference.
  • AAOI +15.48% at $143.45 near 05:40 ET: Q2 revenue reached a record $191.9 million and the company guided Q3 revenue to $255-$290 million. The main counterweight is a $22.8 million GAAP net loss and a very wide $132.00-$147.12 pre-market range.

What to watch today

  • 09:30 ET: compare the opening auction with every delayed range; regular-session liquidity can reset the gaps immediately.
  • After the open: rebuild option bid, ask, IV, volume and open interest; pre-market stock prints are not executable option setups.
  • During the session: watch whether DOCS and TEAM hold above their pre-market lows and whether TTD can reclaim $13.60; these are observed levels, not forecasts.
  • Unverified analyst-action details, social counts and unusual-volume baselines were excluded.
DOCSTEAMTTD

Sources

  1. [1]Doximity fiscal Q1 2027 resultsDoximity / SEC · Accessed 2026-08-07 · Tier 1
  2. [2]Doximity Q2 calendar 2026 revenue and consensus reviewStockStory · Accessed 2026-08-07 · Tier 3
  3. [3]Atlassian Q4 and fiscal 2026 resultsAtlassian / SEC · Accessed 2026-08-07 · Tier 1
  4. [4]Atlassian Q4 results and guidance reviewBenzinga · Accessed 2026-08-07 · Tier 2
  5. [5]The Trade Desk Q2 2026 resultsThe Trade Desk / SEC · Accessed 2026-08-07 · Tier 1
  6. [6]The Trade Desk Q2 results and consensus reviewBenzinga · Accessed 2026-08-07 · Tier 2
  7. [7]FIGS Q2 2026 resultsFIGS / SEC · Accessed 2026-08-07 · Tier 1
  8. [8]FIGS Q2 2026 consensus reviewStockStory · Accessed 2026-08-07 · Tier 3
  9. [9]Applied Optoelectronics Q2 2026 resultsApplied Optoelectronics / SEC · Accessed 2026-08-07 · Tier 1
  10. [10]Nasdaq U.S. market status — 7 August 2026Nasdaq · Accessed 2026-08-07 · Tier 1
  11. [11]Nasdaq delayed pre-market quote — DOCSNasdaq · Accessed 2026-08-07 · Tier 1
  12. [12]Nasdaq delayed pre-market quote — TEAMNasdaq · Accessed 2026-08-07 · Tier 1
  13. [13]Nasdaq delayed pre-market quote — TTDNasdaq · Accessed 2026-08-07 · Tier 1
  14. [14]Nasdaq delayed pre-market quote — FIGSNasdaq · Accessed 2026-08-07 · Tier 1
  15. [15]Nasdaq delayed pre-market quote — AAOINasdaq · Accessed 2026-08-07 · Tier 1
  16. [16]TradingView America structured pre-market scanTradingView · Accessed 2026-08-07 · Tier 3
  17. [17]Cboe delayed option-chain file — DOCSCboe · Accessed 2026-08-07 · Tier 1
  18. [18]Cboe delayed option-chain file — TEAMCboe · Accessed 2026-08-07 · Tier 1
  19. [19]Cboe delayed option-chain file — TTDCboe · Accessed 2026-08-07 · Tier 1
  20. [20]7 August 2026 Morning ReadYieldCove · Accessed 2026-08-07 · Tier 4
  21. [21]Telemedicine Consult — photograph and license recordWikimedia Commons / Intel Free Press · Accessed 2026-08-07 · Tier 4

This content is for informational and educational purposes only and is not financial advice. Options involve risk and are not suitable for every investor. Do your own research before trading.

Read next